| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8314044 | Clinica Chimica Acta | 2012 | 6 Pages |
Abstract
⺠Matrix metalloproteinases (MMPs) are implicated in cardiovascular complications. ⺠Hemodialysis (HD) may affect MMP-9 levels in end stage kidney disease (ESKD). ⺠MMP-9 polymorphisms may affect MMP-9 levels. ⺠We found MMP-9 polymorphisms affecting HD-induced increases in MMP-9 levels. ⺠Patients with such MMP-9 genetic markers may benefit from MMP inhibitors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Bernardo P. Marson, Riccardo Lacchini, Vanessa Belo, Silvia G. Mattos, Bartira P. da Costa, Carlos E. Poli-de-Figueiredo, Jose E. Tanus-Santos,